JPT Peptide Technologies expands to the USA

Berlin/Germany – October 26, 2004:
JPT Peptide Technologies (JPT), a wholly-owned subsidiary of Berlin-based Jerini AG, has established a corporate office in the USA. From their new location in Fairfax County, Virginia, JPT hopes to strengthen its market position. “Being close to our customers will allow us to insure quality customer support. When you look at a map, it is easy to see that Fairfax County is located in the middle of our biomedical customer base on the east coast,”said Holger Wenschuh, Managing Director of JPT, adding, “JPT’s new office is an excellent strategic location because of its proximity to our customers and to federal decision makers.”

JPT has entered the US after winning a competition among eight German biotechnology companies. The award consists of free business development services and office space in the BioAccelerator, a complex dedicated to the growth of early-stage bioscience and biomedical companies.

As a peptide-based service provider, JPT is world-wide leader in the field of innovative peptide-based products and arrays serving all disciplines of biomedical research and drug development.

About JPT Peptide Technologies GmbH:

JPT Peptide Technologies ( is a biotechnology company based in Berlin. As a leading supplier of innovative peptide-based services and products, JPT has a world renowned customer base throughout the pharmaceutical and biotechnology industries. JPT is a wholly-owned subsidiary of Jerini AG.

For further information please contact:

JPT Peptide Technologies GmbH
Dr. Holger Wenschuh
Managing Director
Volmerstr. 5
12489 Berlin/Germany
Phone: +49 - 30 - 6392 - 7880
Fax: +49 - 30 - 6392 - 5501

Stay in touch and be the first to receive the latest news!